BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 36766753)

  • 1. A Lipidomics- and Transcriptomics-Based Analysis of the Intestine of Genetically Obese (
    Suriano F; Manca C; Flamand N; Van Hul M; Delzenne NM; Silvestri C; Cani PD; Di Marzo V
    Cells; 2023 Jan; 12(3):. PubMed ID: 36766753
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Exploring the endocannabinoidome in genetically obese (ob/ob) and diabetic (db/db) mice: Links with inflammation and gut microbiota.
    Suriano F; Manca C; Flamand N; Depommier C; Van Hul M; Delzenne NM; Silvestri C; Cani PD; Di Marzo V
    Biochim Biophys Acta Mol Cell Biol Lipids; 2022 Jan; 1867(1):159056. PubMed ID: 34606993
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Germ-free mice exhibit profound gut microbiota-dependent alterations of intestinal endocannabinoidome signaling.
    Manca C; Boubertakh B; Leblanc N; Deschênes T; Lacroix S; Martin C; Houde A; Veilleux A; Flamand N; Muccioli GG; Raymond F; Cani PD; Di Marzo V; Silvestri C
    J Lipid Res; 2020 Jan; 61(1):70-85. PubMed ID: 31690638
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rapid and Concomitant Gut Microbiota and Endocannabinoidome Response to Diet-Induced Obesity in Mice.
    Lacroix S; Pechereau F; Leblanc N; Boubertakh B; Houde A; Martin C; Flamand N; Silvestri C; Raymond F; Di Marzo V; Veilleux A
    mSystems; 2019 Dec; 4(6):. PubMed ID: 31848310
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Three of a Kind: Control of the Expression of Liver-Expressed Antimicrobial Peptide 2 (LEAP2) by the Endocannabinoidome and the Gut Microbiome.
    Shen M; Manca C; Suriano F; Nallabelli N; Pechereau F; Allam-Ndoul B; Iannotti FA; Flamand N; Veilleux A; Cani PD; Silvestri C; Di Marzo V
    Molecules; 2021 Dec; 27(1):. PubMed ID: 35011234
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel insights into the genetically obese (ob/ob) and diabetic (db/db) mice: two sides of the same coin.
    Suriano F; Vieira-Silva S; Falony G; Roumain M; Paquot A; Pelicaen R; Régnier M; Delzenne NM; Raes J; Muccioli GG; Van Hul M; Cani PD
    Microbiome; 2021 Jun; 9(1):147. PubMed ID: 34183063
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alterations of brain endocannabinoidome signaling in germ-free mice.
    Manca C; Shen M; Boubertakh B; Martin C; Flamand N; Silvestri C; Di Marzo V
    Biochim Biophys Acta Mol Cell Biol Lipids; 2020 Dec; 1865(12):158786. PubMed ID: 32795503
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of selenium on the intestinal microbiome-eCBome axis in the context of diet-related metabolic health in mice.
    Guevara Agudelo FA; Leblanc N; Bourdeau-Julien I; St-Arnaud G; Lacroix S; Martin C; Flamand N; Veilleux A; Di Marzo V; Raymond F
    Front Immunol; 2022; 13():1028412. PubMed ID: 36439185
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Investigating the alterations of endocannabinoidome signaling in the human small intestine in the context of obesity and type 2 diabetes.
    Rakotoarivelo V; Allam-Ndoul B; Martin C; Biertho L; Di Marzo V; Flamand N; Veilleux A
    Heliyon; 2024 Mar; 10(6):e26968. PubMed ID: 38515705
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assessment of the Effects of Dietary Vitamin D Levels on Olanzapine-Induced Metabolic Side Effects: Focus on the Endocannabinoidome-Gut Microbiome Axis.
    Abolghasemi A; Manca C; Iannotti FA; Shen M; Leblanc N; Lacroix S; Martin C; Flamand N; Di Marzo V; Silvestri C
    Int J Mol Sci; 2021 Nov; 22(22):. PubMed ID: 34830242
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Altered endocannabinoidome bioactive lipid levels accompany reduced DNBS-induced colonic inflammation in germ-free mice.
    Venneri T; Giorgini G; Leblanc N; Flamand N; Borrelli F; Silvestri C; Di Marzo V
    Lipids Health Dis; 2023 May; 22(1):63. PubMed ID: 37189092
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Changes in gut microbiota control inflammation in obese mice through a mechanism involving GLP-2-driven improvement of gut permeability.
    Cani PD; Possemiers S; Van de Wiele T; Guiot Y; Everard A; Rottier O; Geurts L; Naslain D; Neyrinck A; Lambert DM; Muccioli GG; Delzenne NM
    Gut; 2009 Aug; 58(8):1091-103. PubMed ID: 19240062
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neurobiological Processes Induced by Aerobic Exercise through the Endocannabinoidome.
    Forteza F; Giorgini G; Raymond F
    Cells; 2021 Apr; 10(4):. PubMed ID: 33920695
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of gut microbiota on plasma oxylipins profile under healthy and obesogenic conditions.
    Ávila-Román J; Arreaza-Gil V; Cortés-Espinar AJ; Soliz-Rueda JR; Mulero M; Muguerza B; Arola-Arnal A; Arola L; Torres-Fuentes C
    Clin Nutr; 2021 Apr; 40(4):1475-1486. PubMed ID: 33743282
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of repeated lysergic acid diethylamide (LSD) on the mouse brain endocannabinoidome and gut microbiome.
    Inserra A; Giorgini G; Lacroix S; Bertazzo A; Choo J; Markopolous A; Grant E; Abolghasemi A; De Gregorio D; Flamand N; Rogers G; Comai S; Silvestri C; Gobbi G; Di Marzo V
    Br J Pharmacol; 2023 Mar; 180(6):721-739. PubMed ID: 36316276
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of local gut microbiome and intestinal transcriptome responses to rosiglitazone treatment in diabetic db/db mice.
    Madsen MSA; Grønlund RV; Eid J; Christensen-Dalsgaard M; Sommer M; Rigbolt K; Madsen MR; Jelsing J; Vrang N; Hansen HH; Mikkelsen M
    Biomed Pharmacother; 2021 Jan; 133():110966. PubMed ID: 33171401
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Substance P, neurokinin A, vasoactive intestinal polypeptide and gastrin releasing peptide in the intestine and pancreas of spontaneously obese-diabetic mice.
    Bailey CJ; Flatt PR; Deacon CF; Shaw C; Conlon JM
    Regul Pept; 1986 Dec; 16(3-4):339-48. PubMed ID: 2436255
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High-fat diet intake modulates maternal intestinal adaptations to pregnancy and results in placental hypoxia, as well as altered fetal gut barrier proteins and immune markers.
    Gohir W; Kennedy KM; Wallace JG; Saoi M; Bellissimo CJ; Britz-McKibbin P; Petrik JJ; Surette MG; Sloboda DM
    J Physiol; 2019 Jun; 597(12):3029-3051. PubMed ID: 31081119
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gut microbiota and short chain fatty acids partially mediate the beneficial effects of inulin on metabolic disorders in obese ob/ob mice.
    Guo J; Zhang M; Wang H; Li N; Lu Z; Li L; Hui S; Xu H
    J Food Biochem; 2022 May; 46(5):e14063. PubMed ID: 35128673
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sepsis-induced intestinal microvascular and inflammatory responses in obese mice.
    Singer G; Stokes KY; Terao S; Granger DN
    Shock; 2009 Mar; 31(3):275-9. PubMed ID: 18665045
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.